About OmniAb
OmniAb is a company based in Palo Alto (United States) founded in 2012 was acquired by Ligand Pharmaceuticals in December 2015.. The company has 114 employees as of December 31, 2024. OmniAb offers products and services including OmniRat, OmniMouse, OmniChicken, and GEM xPloration. OmniAb operates in a competitive market with competitors including Adimab, Aphios, CDI Labs, QuaDRAD and AbCheck, among others.
- Headquarter Palo Alto, United States
- Employees 114 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Omniab, Inc.
-
Annual Revenue
$26.39 M-22.75as on Dec 31, 2024
-
Net Profit
$-62.03 M-22.55as on Dec 31, 2024
-
EBITDA
$-53.28 M-7.14as on Dec 31, 2024
-
Latest Funding Round
$30 M (USD), Post-IPO
Aug 25, 2025
- Investors
-
Employee Count
114
as on Dec 31, 2024
-
Acquired by
Ligand Pharmaceuticals
(Dec 17, 2015)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of OmniAb
OmniAb is a publicly listed company on the NASDAQ with ticker symbol OABI in USA, operating in the Commercial services sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of OmniAb
OmniAb offers a comprehensive portfolio of products and services, including OmniRat, OmniMouse, OmniChicken, and GEM xPloration. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Enables generation of human antibodies for therapeutic research.
Facilitates antibody production and diversity in drug development.
Supports discovery of single-domain antibodies for various applications.
Offers advanced tools for antibody repertoire exploration.
Unlock access to complete
Funding Insights of OmniAb
- Total Funding Total Funding
- Total Rounds 1
- Last Round Post-IPO — $30.0M
-
First Round
First Round
(25 Aug 2025)
- Investors Count Investors Count
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug, 2025 | Amount | Post-IPO - OmniAb | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in OmniAb
OmniAb has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Ligand Pharmaceuticals. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Pharmaceutical drugs are manufactured and developed in the United States.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by OmniAb
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - OmniAb
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Omniab Comparisons
Competitors of OmniAb
OmniAb operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Adimab, Aphios, CDI Labs, QuaDRAD and AbCheck, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Antibodies are discovered and optimized for autoimmune and infectious diseases.
|
|
| domain | founded_year | HQ Location |
Therapeutics for cancer and infectious diseases are developed.
|
|
| domain | founded_year | HQ Location |
Autoantibody detection and profiling products and services are provided.
|
|
| domain | founded_year | HQ Location |
Antibody drug discovery platform
|
|
| domain | founded_year | HQ Location |
Developer of human therapeutic antibodies
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Omniab
Frequently Asked Questions about OmniAb
When was OmniAb founded?
OmniAb was founded in 2012 and raised its 1st funding round 13 years after it was founded.
Where is OmniAb located?
OmniAb is headquartered in Palo Alto, United States. It is registered at Palo Alto, California, United States.
How many employees does OmniAb have?
As of Dec 31, 2024, the latest employee count at OmniAb is 114.
What is the annual revenue of OmniAb?
Annual revenue of OmniAb is $26.39M as on Dec 31, 2024.
What does OmniAb do?
OmniAb was founded in 2012 and is based in Palo Alto, United States, within the biotechnology sector. Three transgenic platformsOmniRat, OmniMouse, and OmniFlicare employed to generate mono- and bispecific human antibodies. These systems, utilizing patented technology, enable diverse antibody repertoires with high affinity and stability. Licensing agreements are extended to pharmaceutical and biotech firms worldwide, covering various targets, indications, and territories through flexible terms.
Who are the top competitors of OmniAb?
What products or services does OmniAb offer?
OmniAb offers OmniRat, OmniMouse, OmniChicken, and GEM xPloration.
Is OmniAb publicly traded?
Yes, OmniAb is publicly traded on NASDAQ under the ticker symbol OABI.
Who are OmniAb's investors?
OmniAb has 1 investor. Key investors include Ligand Pharmaceuticals.
What is OmniAb's ticker symbol?
The ticker symbol of OmniAb is OABI on NASDAQ.